LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
NHTC
Natural Health Trends Corp.
There isn't enough reported data to score NHTC yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
NHTC Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Strong |
NHTC's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
NHTC PE Valuation
NHTC has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
NHTC Forward outlook
There aren't enough analyst estimates for NHTC to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over NHTC on earnings, with more consistent year-over-year improvement.
NHTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.15 | -$0.13 |
| Q2 2026 | -$0.16 | -900% |
| Q1 2026 | -$0.11 | -375% |
| Q4 2025 | -$0.08 | -260% |
| Q3 2025 | -$0.02 | -129% |
| Q2 2025 | $0.02 | -78% |
| Q1 2025 | $0.04 | -20% |
| Q4 2024 | $0.05 | 0% |
NHTC is still losing money, but far less than before: $0.15 per share over the past year, against $0.52 at its worst in late 2019.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over NHTC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
NHTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.6M | -20% |
| Q2 2026 | $7.6M | -23% |
| Q1 2026 | $9.2M | -14% |
| Q4 2025 | $9.7M | -10% |
| Q3 2025 | $9.5M | -11% |
| Q2 2025 | $9.8M | -6.3% |
| Q1 2025 | $10.7M | -2% |
| Q4 2024 | $10.8M | -0.8% |
NHTC's revenue has slid since its 2019 peak: $8M last quarter, down 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.7% | +1.6 points |
| Q2 2026 | -8.5% | -5.1 points |
| Q1 2026 | -5.2% | -1.9 points |
| Q4 2025 | -6.5% | -2.6 points |
| Q3 2025 | -5.2% | -2.6 points |
| Q2 2025 | -3.4% | -1.1 points |
| Q1 2025 | -3.2% | +0.1 points |
| Q4 2024 | -3.9% | -1.7 points |
NHTC has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
NHTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1M | -1670% |
| Q2 2026 | -$1.7M | +$4M |
| Q1 2026 | -$912K | -295% |
| Q4 2025 | -$964K | -1518% |
| Q3 2025 | $70K | +$513K |
| Q2 2025 | -$5.6M | -$2.1M |
| Q1 2025 | $468K | -13% |
| Q4 2024 | $68K | +$151K |
NHTC has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
NHTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -1K shares |
| 1 year | -25% | -2.9M shares |
| 3 years | -25% | -2.9M shares |
| 5 years | -25% | -2.8M shares |
| Available history | -21% | -2.3M shares |
NHTC has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $28,000 |
| Q2 2026 | — |
| Q1 2026 | $5.9M |
| Q4 2020 | — |
| Q3 2020 | — |
| Q4 2019 | $553,000 |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NHTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | -180.3x | Net Cash |
| Q2 2022 | -72.2x | Net Cash |
| Q1 2022 | -64.0x | Net Cash |
| Q4 2021 | -44.8x | Net Cash |
| Q3 2021 | -31.4x | Net Cash |
| Q2 2021 | -30.4x | Net Cash |
NHTC has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
NHTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 22.2 | Oversold |
| Stochastic | 2.6 | Oversold |
NHTC's weekly RSI is 22 (oversold) and its Stochastic is 3 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
NHTC PE vs Consumer Cyclical Sector
| Metric | NHTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
NHTC has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
NHTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.85 | 14% below |
| 20 week MA | $1.37 | 47% below |
| 50 week MA | $2.35 | 69% below |
| 100 week MA | $3.48 | 79% below |
| 200 week MA | $4.69 | 84% below |
NHTC is in a downtrend: it's below all five of its weekly moving averages, and 84% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has the edge over NHTC on returns for 2026, with the stronger performance.
NHTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.38 | $5.15 | -4.3% |
| 2021 | $5.15 | $6.63 | +29% |
| 2022 | $6.63 | $3.57 | -46% |
| 2023 | $3.57 | $5.86 | +64% |
| 2024 | $5.86 | $4.49 | -23% |
| 2025 | $4.49 | $3.32 | -26% |
| 2026 YTD | $3.32 | $0.73 | -78% |
NHTC has finished lower in four of the last six years. It's down 78% so far in 2026.